Summit Therapeutic (SMMT US, +1, 28-Mar-24)

Ankur Dhingra (CFO since 2022) purchased $375,000 of stock on the 26th of March at $3.75, increasing his stake by 39%. This is much his largest purchase or subscription and also much the highest price he has paid. His only previous clean purchase was for $44,000 of stock at $2.17 and it’s very notable to see him now buying in size at a higher price. 

Mahkam Zanganeh (Co-CEO since 2022, joined 2020) purchased $411,000 of stock on the 26th of March. Whilst modest relative to her 3.6% stake and previous subscriptions, this is her first proper-sized clean purchase. 

We are ranking the stock +1.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.